Optimising Screening for the Cardiotoxic Effects of Cancer Therapy
NCT06817044
·
clinicaltrials.gov ↗
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Ventricular Dysfunction
Cardiotoxicity
Chemotherapeutic Toxicity
Sponsor
Barts & The London NHS Trust